Try GOLD - Free
Ozempic debuts with a ₹2,200-a-week price tag
Mint Hyderabad
|December 13, 2025
for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.
-
The market for anti-obesity drugs in India, which was worth about ₹600 crore as of July 2025, could grow to ₹2,000-3,000 crore by FY27, Shrikant Akolkar, pharma research analyst at Nuvama, had earlier told Mint.
Originally developed to treat type-2 diabetes, GLP-1 drugs showed significant potential to treat weight loss and were approved to target obesity specifically. In the last few years, they have taken the world by storm.
This story is from the December 13, 2025 edition of Mint Hyderabad.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Hyderabad
Mint Hyderabad
Quality fears to spur premium dairy boom in cities
March, while Akshayakalpa is said to be in talks to raise ₹350 crore from Temasek's ABC Impact and others.
1 mins
December 18, 2025
Mint Hyderabad
Coverage challenge
Can India's insurance sector help mobilize more long-term capital? How much of a differ- ence will the Centre's proposal of raising its foreign direct investment (FDI) cap to 100% from 74% make?
1 min
December 18, 2025
Mint Hyderabad
TCS lifts curtain to peg yearly revenue from Al at $1.5 bn
In a first for homegrown IT services companies, Tata Consultancy Services Ltd (TCS) has said it earns $11 billion from disruptive technologies, including $1.5 billion from AI.
1 min
December 18, 2025
Mint Hyderabad
India summons B'desh envoy over security concerns in Dhaka
India on Wednesday summoned Bangladesh envoy Riaz Hamidullah and lodged its protest over plans by certain extremist elements to create a security situation around the Indian mission in Dhaka.
1 min
December 18, 2025
Mint Hyderabad
'Rising MF firepower softens impact of FII outflows'
There was a time when heavy foreign investor selling could rattle Indian equity markets.
2 mins
December 18, 2025
Mint Hyderabad
Should you invest yourself or let professionals do the job for you?
Ask whether your performance as a fund manager is superior on the basis of an objective assessment
4 mins
December 18, 2025
Mint Hyderabad
IOB OFS opens for subscription
The Indian Overseas Bank's (IOB's) Offer-for-Sale (OFS) opened on Wednesday for non-retail investors at a floor price of ₹34 per share.
1 min
December 18, 2025
Mint Hyderabad
Let ‘digital collateral’ for loans drive credit inclusion
India's economy grew at a faster-than-expected 8.2% in the last quarter, driven by manufacturing and services as well as a recovery in private consumption.
3 mins
December 18, 2025
Mint Hyderabad
NCLT permits rejig at Flipkart
NCLT has approved merger of eight Flipkart entities, taking it closer to an IPO.
1 min
December 18, 2025
Mint Hyderabad
Mizuho buys majority stake in Avendus for $523 million
Japanese bank to pick up 61.6-78.3% of Avendus shares, making it a consolidated subsidiary
2 mins
December 18, 2025
Listen
Translate
Change font size